SG11202006710RA - Preparative process of two 4-{[(2s)-2-{4-[5-chloro-2-(1h-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2h)-yl}butanoyl]amino}-2-fluorobenzamide derivatives - Google Patents

Preparative process of two 4-{[(2s)-2-{4-[5-chloro-2-(1h-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2h)-yl}butanoyl]amino}-2-fluorobenzamide derivatives

Info

Publication number
SG11202006710RA
SG11202006710RA SG11202006710RA SG11202006710RA SG11202006710RA SG 11202006710R A SG11202006710R A SG 11202006710RA SG 11202006710R A SG11202006710R A SG 11202006710RA SG 11202006710R A SG11202006710R A SG 11202006710RA SG 11202006710R A SG11202006710R A SG 11202006710RA
Authority
SG
Singapore
Prior art keywords
oxopyridin
butanoyl
triazol
chloro
methoxy
Prior art date
Application number
SG11202006710RA
Other languages
English (en)
Inventor
Julian Egger
Daniel Götz
Michal Sowa
Original Assignee
Bayer Ag
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Bayer Pharma AG filed Critical Bayer Ag
Publication of SG11202006710RA publication Critical patent/SG11202006710RA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
SG11202006710RA 2018-03-15 2019-03-08 Preparative process of two 4-{[(2s)-2-{4-[5-chloro-2-(1h-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2h)-yl}butanoyl]amino}-2-fluorobenzamide derivatives SG11202006710RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18161983 2018-03-15
PCT/EP2019/055815 WO2019175043A1 (en) 2018-03-15 2019-03-08 Preparative process of two 4-{[(2s)-2-{4-[5-chloro-2-(1h-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2h)-yl}butanoyl]amino}-2-fluorobenzamide derivatives

Publications (1)

Publication Number Publication Date
SG11202006710RA true SG11202006710RA (en) 2020-08-28

Family

ID=61683650

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202006710RA SG11202006710RA (en) 2018-03-15 2019-03-08 Preparative process of two 4-{[(2s)-2-{4-[5-chloro-2-(1h-1,2,3-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridin-1(2h)-yl}butanoyl]amino}-2-fluorobenzamide derivatives

Country Status (28)

Country Link
US (1) US11542245B2 (ko)
EP (2) EP3889147A1 (ko)
JP (1) JP7287978B2 (ko)
KR (1) KR20200131241A (ko)
CN (1) CN111770917B (ko)
AR (1) AR117400A1 (ko)
AU (1) AU2019236369B2 (ko)
BR (1) BR112020018562A2 (ko)
CA (1) CA3093733A1 (ko)
CL (1) CL2020002371A1 (ko)
DK (1) DK3765452T3 (ko)
ES (1) ES2920449T3 (ko)
HR (1) HRP20220565T1 (ko)
HU (1) HUE058796T2 (ko)
IL (2) IL300463A (ko)
JO (1) JOP20200232B1 (ko)
LT (1) LT3765452T (ko)
MX (1) MX2020009580A (ko)
PE (1) PE20211395A1 (ko)
PL (1) PL3765452T3 (ko)
PT (1) PT3765452T (ko)
RS (1) RS63338B1 (ko)
SG (1) SG11202006710RA (ko)
SI (1) SI3765452T1 (ko)
TW (1) TWI823911B (ko)
UA (1) UA126940C2 (ko)
UY (1) UY38147A (ko)
WO (1) WO2019175043A1 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220140558A (ko) * 2020-02-11 2022-10-18 케미노바 에이/에스 (r)-2-아미노부탄산으로부터 s-베플루부타미드를 합성하는 방법
EP4304714A1 (en) 2021-03-09 2024-01-17 Bayer Aktiengesellschaft Crystalline forms of (4s)-2 4-chloro-4-ethyl-7 3-fluoro-3 5-methoxy-3 2,5-dioxo-1 4-(trifluoromethyl)-3 2h-6-aza-3(4,1)-pyridina-1(1)-[1,2,3]triazola-2(1,2),7(1)-5 dibenzenaheptaphane-7 4-carboxamide
WO2022189280A1 (en) 2021-03-09 2022-09-15 Bayer Aktiengesellschaft Solvates of (4s)-24-chloro-4-ethyl-73-fluoro-35-methoxy-32,5-dioxo-14-(trifluoro-methyl)-32 h-6- aza-3(4,1)-pyridina-1(1)-[1,2,3]triazola-2(1,2),7(1)-dibenzenaheptaphane-74-carboxamide
CA3212644A1 (en) 2021-03-09 2022-09-15 Bayer Aktiengesellschaft Pharmaceutical dosage forms comprising (4s)-24-chloro-4-ethyl-73-fluoro-35-methoxy-32,5- dioxo-14-(trifluoromethyl)-32h-6-aza-3(4,1)-pyridina-1(1)-[1,2,3]triazola-2(1,2),7(1)- dibenzenaheptaphane-74-carboxamide
WO2023174399A1 (zh) * 2022-03-18 2023-09-21 苏州晶云药物科技股份有限公司 取代的氧代吡啶类衍生物的晶型及其制备方法
CN116535392B (zh) * 2023-06-26 2023-09-05 成都施贝康生物医药科技有限公司 一种氧代吡啶类化合物的制备方法及中间体和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2396079A1 (en) 2000-01-07 2001-07-19 Transform Pharmaceuticals, Inc. High-throughput formation, identification, and analysis of diverse solid-forms
TWI633089B (zh) 2013-03-28 2018-08-21 拜耳製藥股份有限公司 經取代的酮基吡啶衍生物
JO3703B1 (ar) * 2015-07-09 2021-01-31 Bayer Pharma AG مشتقات أوكسوبيريدين مستبدلة
CN107793396B (zh) 2016-08-31 2021-02-26 江苏恒瑞医药股份有限公司 环氧基取代的氧代吡啶类衍生物、其制备方法及其在医药上的应用
EP3898611A1 (en) * 2018-12-17 2021-10-27 Bayer Aktiengesellschaft Substituted oxopyridine derivatives for the treatment and/or prophylaxis of thrombotic or thromboembolic disorders and/or thrombotic or thromboembolic complications
EP3898634A1 (en) * 2018-12-21 2021-10-27 Bayer Aktiengesellschaft Substituted oxopyridine derivatives
MA54521A (fr) * 2018-12-21 2022-03-30 Bayer Ag Dérivés d'oxopyridine substitués

Also Published As

Publication number Publication date
PE20211395A1 (es) 2021-07-27
CA3093733A1 (en) 2019-09-19
SI3765452T1 (sl) 2022-06-30
EP3765452A1 (en) 2021-01-20
ES2920449T3 (es) 2022-08-04
JOP20200232B1 (ar) 2023-09-17
IL277240B1 (en) 2023-09-01
JOP20200232A1 (ar) 2020-09-14
TWI823911B (zh) 2023-12-01
PL3765452T3 (pl) 2022-08-01
KR20200131241A (ko) 2020-11-23
RU2020133706A (ru) 2022-04-18
HUE058796T2 (hu) 2022-09-28
JP2021517573A (ja) 2021-07-26
JP7287978B2 (ja) 2023-06-06
AU2019236369A1 (en) 2020-07-30
UY38147A (es) 2019-10-01
DK3765452T3 (da) 2022-06-27
EP3765452B1 (en) 2022-04-13
IL277240B2 (en) 2024-01-01
UA126940C2 (uk) 2023-02-22
US11542245B2 (en) 2023-01-03
HRP20220565T1 (hr) 2022-06-10
CN111770917B (zh) 2023-09-26
LT3765452T (lt) 2022-05-25
RS63338B1 (sr) 2022-07-29
EP3889147A1 (en) 2021-10-06
BR112020018562A2 (pt) 2020-12-29
AU2019236369B2 (en) 2024-04-18
WO2019175043A1 (en) 2019-09-19
IL300463A (en) 2023-04-01
US20210017152A1 (en) 2021-01-21
PT3765452T (pt) 2022-06-23
CN111770917A (zh) 2020-10-13
CL2020002371A1 (es) 2021-01-29
MX2020009580A (es) 2020-10-05
AR117400A1 (es) 2021-08-04
IL277240A (en) 2020-10-29
TW202002969A (zh) 2020-01-16

Similar Documents

Publication Publication Date Title
IL277240B1 (en) Process for the preparation of two derivatives of 4-{[(2s)-2-{4-[5-chloro-2-(1h-3,2,1-triazol-1-yl)phenyl]-5-methoxy-2-oxopyridine -1-(2h)-yl}butenoyl]amino}-2-fluorobenzamide
IL281196A (en) Process for the preparation of methyl 6-(4,2-dichlorophenyl)-5-[4-[(S3)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-9,8-dihydro-H7-benzo[ 7]Anolene-2-carboxylate
EP4192831A4 (en) HETEROCYCLIC GLP-1 AGONISTS
MX2020005818A (es) Triazol azoles de acido ciclohexilo como antagonistas de acido lisofosfatidico (lpa).
EP3411036A4 (en) 3,5-DISUBSTITUTED PYRAZOLE AS CHECKPOINT KINASE 1 (CHK1) INHIBITORS, AND THEIR PREPARATION AND USE
SI3666768T1 (sl) Postopek priprave kristalne oblike 1-((2R, 4R)-2-(1H-benzo(D)imidazol -2-il)-1-metilpiperidil-4-il)-3-(4-cianofenil)urea maleata; kristalne oblike 1-((2R, 4R)-2-(1H-benzo(d)imidazol-2-il)-1-metilpiperidin-4-il -3-(4-cianofenil)urea imidazol kompleksa (1:1)
MX2021012849A (es) Una 7-h-pirrolo[2,3-d]pirimidina inhibidora de jak.
EP3952865A4 (en) HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS FOR THERAPEUTIC USES
EP3233824A4 (en) (s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2h)-yl)-2-oxoethyl)-3- (methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations
MX2019015612A (es) Composicion farmaceutica y metodo para preparar el mismo.
PH12017500123A1 (en) Crystal of azole benzene derivative
EP3233079A4 (en) (s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2h)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations
PH12017500124B1 (en) Azole benzene derivative and crystalline form thereof
PH12019501165A1 (en) Drug for treating cocaine addiction or preventing recurrence of same
RU2022129311A (ru) Способ получения двух 4-{ [(2s)-2-{ 4-[5-хлор-2-(1h-1,2,3-триазол-1-ил)фенил]-5-метокси-2-оксопиридин-1(2h)-ил} бутаноил]амино} -2-фторбензамидных производных
ZA202204542B (en) Process for the production of 5-(4-((2 s,5 s)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1 h-1,2,4-triazol-3-amine
MX2018008342A (es) Composicion farmaceutica que comprende un derivado azoico de pirazolona biciclo-sustituido o una sal del mismo y metodo de preparacion de los mismos.
EP3166404A4 (en) Improved process for preparation of 4-(1-(4-(perfluoroethoxy)phenyl)-1h-1,2,4-triazol-3-yl)benzoyl azide